RECENT NEWS

Bioimaging firm Molecular Instruments has announced a significant advancement in dermatological diagnostics through the successful development and implementation of novel laboratory-developed tests (LDTs) at the Department of Dermatology at Yale School of Medicine.

Life sciences firm Fujifilm Irvine Scientific has entered into an agreement to sell its Medical Media Business Unit (MBU) to Astorg, a leading pan-European private equity firm with an extensive track record in global healthcare investments.

Using single cell analysis and spatial omics, a multi-national research team has shown in detail how multiple myeloma begins to spread in the body. The recently published results could contribute to more precise diagnostics and therapy, according to the study authors.

AliveDx has announced that its MosaiQ AiPlex CTDplus multiplex assay for the diagnosis and management of systemic autoimmune rheumatic diseases (SARDs) has received the IVDR-CE mark

A novel biomarker test developed at the University of Pittsburgh is able to detect Alzheimer's disease-related pathology earlier than other methods, a new study has discovered.

The Royal College of Pathologists (RCPath) has made a submission to Phase 2 of the Government's Spending Review, which will deliver the government’s ‘Plan for Change’, asking for investment in the pathology workforce, IT, and estates.

Registration is now open for the British Society for Microbial Technology’s annual conference, which is marking its 40th anniversary this year.

BD (Becton, Dickinson and Company) has announced a plan to separate BD's Biosciences and Diagnostic Solutions business from the rest of the company.

Precision medicine firm Oxford BioDynamics has announced the publication of compelling results involving its technology in a multi-centre study using blood to detect colorectal cancer (CRC), including early stage, and non-cancerous polyps with high accuracy.

Facility Monitoring Systems (FMS), a trusted provider of contamination control solutions, is excited to announce that it has joined Trescal, a global leader in calibration services.

Severn Pathology in Bristol has recently gone live with its fourth LIAISON XL system. What makes this one a bit more special is that it marks production of Diasorin’s 7,000th LIAISON XL instrument.

A new diagnostic test being trialled across eight NHS hospitals could transform how thyroid lumps are assessed, potentially sparing hundreds of patients from unnecessary surgery.

The Institute of Biomedical Science (IBMS) has officially launched Congress 2025, which it says will be its most comprehensive yet, featuring diverse education, cutting-edge exhibitions, and unparalleled networking opportunities.

Twelve new mpox vaccination sites have opened across England, making it easier for eligible people to get protected.

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for individualised mRNA cancer immunotherapies (colloquially referred to as cancer vaccines).

The NHS will focus on delivering faster treatment for hundreds of thousands of patients – including for planned surgeries and emergency care – as the number of national targets is almost halved under new guidance to reform services.

A major new study aimed at identifying blood tests that could help diagnose dementia more accurately and quickly than current methods has begun recruiting patients from January 2025.

The UK Health Security Agency (UKHSA) has published an updated antimicrobial stewardship tool to support healthcare professionals across the UK prescribe the most appropriate antibiotics for patients, while protecting against antimicrobial resistance (AMR).

The UK Health Security Agency (UKHSA) has launched a world-first metagenomics initiative to aid in the rapid detection of infectious diseases that could threaten the UK.

The next POCT Innovators event, ‘Clinical Innovations EXPO – Breaking Through the Adoption Barriers’ will take place Thursday 15 May in Nottingham.